As it investigates the root cause of an impurity discovered in valsartan, FDA extends its studies to APIs with similar synthesis processes. / read more /
Check out the PharmTech Europe Supplement on APIs,
Excipients, and Manufacturing,
includes the
CPhI Worldwide
Planning Guide.
Alcami and the University of North Carolina Wilmington received a grant worth $1.12 million (approximately EUR 1 million) from the National Institute for Innovation in Manufacturing Biopharmaceuticals to prepare students for careers in pharmaceutical sciences. / read more /
Research from the Perelman School of Medicine at the University of Pennsylvania suggests that a universal flu vaccine that protects people against most influenza strains is one step closer to reality. / read more /
The European Commission's proposed amendment on supplementary protection certificates (SPC) waivers has sparked opposing views from drug originators and producers of generic drugs and biosimilars. / read more /
The European Commission (EC) has approved GlaxoSmithKline’s (GSK) Nucala (mepolizumab) as an add-on treatment for severe refractory eosinophilic asthma in pediatric patients six to 17 years old. / read more /
The purchase of Novartis’ cystic fibrosis products TOBI Podhaler and TOBI solution for $463 million (EUR 400 million) is expected to strengthen Mylan’s global respiratory portfolio. / read more /
A collaboration integrates Sartorius Stedim Biotech’s BIOSTAT STR bioreactors and Repligen’s XCell ATF cell-retention control technology to create simplified, scalable equipment for intensified cell culture. / read more /
Commonly referred to as the future of advanced pharmaceutical manufacturing, continuous manufacturing has gained major traction in the past 10 years to enable significant improvements in efficiency, safety, cost, and speed to market. / read more /
Real-life examples illustrate how to reduce the risks for each transferring partner and ensure that the development process meets regulatory requirements. / read more /
Make Compliance a Competitive Advantage
Are you looking to ensure compliance to the latest demanding regulations? Do you need to be able to easily demonstrate control of your data? With Thermo Scientific™ Chromeleon™ CDS software you can rest assured.
/Read more/
New C2MAP automated pretreatment module
Complete LC/MS solution for cell culture analysis
Celebrating this year the 50th anniversary of its presence in Europe, Shimadzu emphasizes its Excellence in Science approach through the release of the new C2MAP-2000 automated pretreatment module for cell culture media analysis. / Read more/
This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.
